Novak & Powell Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $313K | Sell |
12,896
-155
| -1% | -$3.76K | 0.22% | 101 |
|
|
2025
Q1 | $331K | Buy |
13,051
+134
| +1% | +$3.4K | 0.21% | 101 |
|
|
2024
Q4 | $343K | Buy |
12,917
+52
| +0.4% | +$1.38K | 0.2% | 98 |
|
|
2024
Q3 | $372K | Buy |
12,865
+47
| +0.4% | +$1.36K | 0.22% | 95 |
|
|
2024
Q2 | $359K | Buy |
12,818
+24
| +0.2% | +$672 | 0.22% | 94 |
|
|
2024
Q1 | $355K | Sell |
12,794
-152
| -1% | -$4.22K | 0.27% | 88 |
|
|
2023
Q4 | $373K | Buy |
+12,946
| New | +$373K | 0.25% | 87 |
|